Selected article for: "cardiovascular disease and death rate"

Author: Ferguson, Jessica; Rosser, Joelle I.; Quintero, Orlando; Scott, Jake; Subramanian, Aruna; Gumma, Mohammad; Rogers, Angela; Kappagoda, Shanthi
Title: Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March–April 2020
  • Cord-id: mc77aqbq
  • Document date: 2020_8_25
  • ID: mc77aqbq
    Snippet: Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13–April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (2
    Document: Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13–April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • abnormal result and admission test: 1
    • active malignancy and acute kidney injury: 1, 2
    • active malignancy and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7
    • active malignancy and admission test: 1, 2
    • active malignancy and long term rehabilitation: 1
    • acute care and admission chest: 1, 2, 3, 4, 5, 6, 7, 8
    • acute care and admission chest radiograph: 1
    • acute care and admission test: 1, 2, 3, 4, 5, 6
    • acute care and long term acute care hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute care and long term rehabilitation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute care and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8
    • acute care facility and long term acute care hospital: 1, 2
    • acute care facility and long term rehabilitation: 1, 2
    • acute care hospital and admission test: 1, 2, 3
    • acute care hospital and long term acute care hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute care hospital and long term rehabilitation: 1, 2
    • acute kidney injury and admission chest: 1, 2, 3
    • acute kidney injury and admission outpatient: 1
    • acute kidney injury and admission test: 1, 2, 3